Figure 1.
The relative abundance and prevalence (fraction of HCT recipients with at least 1 butyrogen present) of butyrogens after the onset of acute GVHD of the gut stratified by steroid responsive or refractory GVHD. All plots are rolling averages. P values from mixed-effects modeling from day 0 to +21 (with gray background) relative to the peak of acute GVHD symptoms. Black dashed line is the median value for healthy donors.

The relative abundance and prevalence (fraction of HCT recipients with at least 1 butyrogen present) of butyrogens after the onset of acute GVHD of the gut stratified by steroid responsive or refractory GVHD. All plots are rolling averages. P values from mixed-effects modeling from day 0 to +21 (with gray background) relative to the peak of acute GVHD symptoms. Black dashed line is the median value for healthy donors.

Close Modal

or Create an Account

Close Modal
Close Modal